What Every Provider Type Should Know and Do for MMH

Implementing MH Collaborative Care
in Private Practices and Beyond

Complimentary Collaborative Care Training for Psychiatrists through the APA

Association Between Severe Maternal Morbidity and Psychiatric Illness Within 1 Year of Hospital Discharge After Delivery

Looking After your Mental Health – Things you can do to Support your Mental Wellbeing


Billing Resources

Coding for Perinatal Depression

Care Coordination Billing Coding

 

Share Your Maternal Mental Health Care/Claim/Payment Denial Story

Pregnant-02.png

Though many women have health insurance at the time of their maternal mental health challenges, insurance can still be a significant barrier to care.

If you've experienced trouble providing care due to insurance company policies, please take 2 minutes to share those experiences here. Your stories will help us drive change.



Learn about the various Maternal Mental Health Disorders, the differences between them, risk factors and treatment options. The course is designed for providers, administrators and public health employees, though all are welcome. Listen to a previously recorded webinar here. For a list of the resources shared during the training click here. Upcoming live webinars are listed here.


Free E-Learning Program on Cultural Competency for Behavioral Health Professionals

The U.S. Health and Human Services Office of Minority Health (OMH) program, available via OMH’s Think Cultural Health website, is designed to develop behavioral health providers' knowledge and skills related to culturally and linguistically appropriate services (CLAS). OMH encourages all certified counselors, nurses, psychiatrists, psychologists and social workers to take this program and earn up to five continuing education credits at no cost.

The program’s 4 courses cover:
• Connections between culture and behavioral health
• The impact of cultural identity on interactions with clients
• Ways to engage, assess and treat clients from diverse backgrounds

Learn more about the program | Spread the word - access the toolkit

Are you looking for other free e-learning programs on cultural competency? Check out the suite of Think Cultural Health e-learning programs at thinkculturalhealth.hhs.gov/education


The American College of Obstetricians and Gynecologists (ACOG) Offers Resources for Ob-GYNs and Women’s Health Care Providers

MentalHealthAwareness.ashx.jpg

• Webinar addressing Perinatal Mood and Anxiety Disorders - Strategies for Women's Health Care Providers.

Visit the Women’s Health Care Physicians page for more resources like:
• Committee Opinion: Screening for Perinatal Depression
• Practice Bulletin: Use of Psychiatric Medications During Pregnancy and Lactation (members only)



Developing a Treatment Plan and More

Video and transcript.


Safety Action Series

Reproductive Psychiatry: Navigating Treatment Options in Maternal Mental Health

Council on Patients Safety in Women’s Health Care

Objectives

  • Review the importance of collaborative care in maternal mental health, i.e. among obstetric providers, psychiatrists, and social workers

  • Discuss approaches to maternal mental health screening and medications

  • Consider important next steps when test results come back positive for perinatal/postpartum depression and anxiety

  • Explore strategies for providing personalized care to every woman, including in cases of trauma

Speakers

Brandon-Headshot.jpg

Claire Brandon, MD
Board Certified Psychiatrist
Consultation Liaison Psychiatry
New York City, New York

Randi Delirod, MA, LMSW
Behavioral Health Clinician
Mental Health Service Corps
New York City, New York

Slides and Audio Recording of teleconference.


Zulresso, the first medicine specifically approved by the FDA for the treatment of postpartum depression.

Zulresso, the first medicine specifically approved by the FDA for the treatment of postpartum depression.

Healthcare settings that elect to administer Zulresso must enroll and become certified in the U.S. Food and Drug Administration’s (FDA) Risk Evaluation and Mitigation Strategy (REMS) program. The REMS is required by the FDA to ensure the potential benefits of therapy outweigh its risks. Zulresso is available only through a restricted program under a REMS called the Zulresso REMS because excessive sedation or sudden loss of consciousness can result in serious harm. REMS certified centers will be trained, complete a knowledge assessment, officially enroll, and then implement necessary processes and procedures to administer the therapy.

Learn more about certified sites by calling 844-4-sagerx or visit SageCentralSupport.com.


Complex PTSD in ICD-11

Complex PTSD, new Diagnosis/Classification (ICD-11) by the World Health Organization

Video